U.S. Media Attention Focuses! 365mc Leads ‘Innovative Body Contouring’ with MOU Agreement with Global Bio Company!
365mc
Hello, this is LipoManiac 365mc! This is an Obesity specialized hospital 365mc. We bring youexciting news that will shake up the global medical marketonce again!
On July 11th, 365mc officially announced its partnership with Israel's global bio company Raziel Therapeutics, signing a memorandum of understanding (MOU) to jointly develop and conduct clinical trials for the innovative fat-reduction injection treatment RZL-012 in South Korea.
RZL-012 is a next-generation non-surgical fat-reduction treatment that can significantly reduce fat in specific areas with a single injection. It is particularly gaining attention for its potential to contour body lines and reduce double chins.
It has already proven its effect in global clinical trials by selectively destroying fat cells and reducing fat volume, and it is now on the verge of entering Phase 3 clinical trials, attracting global attention.
With this agreement, 365mc will be a strong partner in the entire process, from establishing the clinical strategy for RZL-012 in South Korea to its development and commercialization.
Furthermore, 365mc is planning to combine its own fat-extracting injection technology, LAMS, with RZL-012 to create a new body-contouring solution that encompasses both injections and treatments.
This goes beyond just a new procedure; it is 365mc's groundbreaking and innovative global challenge to make "the era where a single injection can reduce fat" a reality.
As part of this collaboration, 365mc will also make a strategic investment in Raziel Therapeutics to jointly drive innovation in non-surgical fat-reduction treatments.
365mc's efforts to expand its global business and technological cooperation have generated significant attention both domestically and internationally, with numerous major U.S. media outlets focusing on this news.
U.S. media have covered 365mc's innovative fat-reduction treatments and this global partnership extensively, highlighting the fact that our medical technology has strong competitiveness on the world stage.
This is not just a news report; it is a clear testament to the recognition of 365mc's technology and brand value in the global market and a proud achievement marking our position as the protagonist of global innovation.
Through this MOU, another innovative attempt is becoming a reality.
365mc will continue to challenge without stopping.
We will do our best to bring even greater changes to our customers in the future.
Thank you.
Results may vary from person to person.